OpenAI says 300M people use ChatGPT weekly as it pushes 'Intelligence Age'

OpenAI is framing ChatGPT as the latest in a long line of transformative human tools, placing it alongside fire, the wheel, and the internet in a new brand campaign. The company says more than 300 million people now use the chatbot weekly, a staggering figure for a product barely two years old. In January alone, one in seven American adults fired it up. The speed of adoption is jarring even by modern tech standards. Netflix needed about a decade to hit 100 million users; Fortnite took close to a year. ChatGPT crossed that line in two months.

That velocity is a big part of the pitch. OpenAI’s first-ever Super Bowl ad was a 60-second spot depicting human progress from fire to DNA sequencing, ending with a blinking ChatGPT cursor. The creative team used Sora, the company’s video generation tool, as a rapid-fire brainstorming partner to meet the compressed production timeline. Chief Marketing Officer Kate Rouch noted that the people most actively shaping the future with AI skew young—nearly eight in 10 users are under 35. California State University is now rolling out ChatGPT to half a million students, a signal that the tool is moving beyond novelty and into institutional infrastructure.

The blog post, attributed to OpenAI’s editorial team, leans hard on the idea that AGI will spawn entire new industries and fields of study. It points to current use cases: accelerating research at US National Laboratories, speeding up drug development, helping teachers craft personalized lesson plans, and even protecting military personnel from drone attacks. The through-line is clear—this isn’t just a consumer toy. Sam Altman’s “Intelligence Age” framing suggests a future where AI doesn’t replace human creativity but supercharges it, though the company is careful to emphasize that the ad itself was a human-led effort with AI assistance.

What’s left unsaid is how the economics of this scale actually work when the product is largely free. OpenAI mentions economic growth and medical breakthroughs, but the blog post reads more like a vision statement than a roadmap. The ambition is undeniable. Whether the reality catches up before the hype cycle turns is the question hanging over the whole enterprise.